Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 14 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

57%

8 trials in Phase 3/4

Results Transparency

100%

5 of 5 completed trials have results

Key Signals

5 recruiting5 with results

Enrollment Performance

Analytics

Phase 3
8(66.7%)
N/A
2(16.7%)
Phase 2
2(16.7%)
12Total
Phase 3(8)
N/A(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials
NCT05438407Phase 3Active Not Recruiting

Pediatric Patients Aged 4 to 11 Years With APDS

Role: collaborator

NCT07147569Recruiting

TAMBE Japan Post-Marketing Surveillance

Role: collaborator

NCT07457918Phase 3Recruiting

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

Role: collaborator

NCT07049913Recruiting

TBE Zone 2 PMS in Japan

Role: collaborator

NCT05693129Phase 3Active Not Recruiting

Pediatric Patients Aged 1 to 6 Years With APDS

Role: collaborator

NCT04796350Not ApplicableRecruiting

RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

Role: collaborator

NCT02668692Phase 3Completed

LEO 80185 Gel (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Psoriasis

Role: collaborator

NCT05814159Phase 3Active Not Recruiting

A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)

Role: collaborator

NCT06249997Phase 3Unknown

An Open-Label Study to Assess the Safety & Efficacy of Leniolisib in Japanese Patients With APDS

Role: collaborator

NCT06236750Not ApplicableRecruiting

Post-Marketing Surveillance of Dehydrated Human Amnion/Chorion Membrane (DHACM) in Non-Ischemic Chronic Wounds

Role: collaborator

NCT03093870Phase 2Completed

Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer

Role: collaborator

NCT02607280Phase 3Completed

DS-5565 Phase III Study for Renal Impairment in Japanese Subjects

Role: collaborator

NCT02318706Phase 3Completed

DS-5565 Phase III Study for Diabetic Peripheral Neuropathic Pain

Role: collaborator

NCT01194804Phase 2Completed

E07-001: Safety and Efficacy Extension Study of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients

Role: collaborator

All 14 trials loaded